Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Cyclerion Therapeutics Inc | CYCN | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.03 |
Recent News
Date | Time | Source | Heading |
---|---|---|---|
11/24/2023 | 13:06 | EDGAR2 | Form 8-K - Current report |
11/13/2023 | 16:30 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
10/23/2023 | 16:58 | EDGAR2 | Form 8-K - Current report |
7/31/2023 | 07:00 | GLOBE | Tisento Launches with $81 Million From Top-Tier Investor.. |
7/28/2023 | 16:48 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
7/19/2023 | 17:27 | EDGAR2 | Form 8-K - Current report |
7/12/2023 | 16:12 | EDGAR2 | Form 8-K - Current report |
6/01/2023 | 16:00 | GLOBE | Cyclerion Regains Compliance with Nasdaq Minimum Bid Price.. |
5/15/2023 | 13:00 | GLOBE | Cyclerion Announces Reverse Stock Split |
5/11/2023 | 18:00 | GLOBE | Cyclerion Announces Definitive Agreement for Zagociguat and.. |
4/03/2023 | 07:30 | GLOBE | Cyclerion Therapeutics Enters into Exclusive Negotiation.. |
3/27/2023 | 07:00 | GLOBE | Cyclerion Therapeutics Receives U.S. FDA Orphan Drug.. |
3/22/2023 | 16:40 | GLOBE | Cyclerion Reports Corporate Update and Full Year 2022.. |